Brief: Joseph Dossantos, Acting CFO, Leaves Celularity On Feb 27, 2026 - SEC Filing
05/03/2026 23:15
March 5 (Reuters) - SEC Filing: CELULARITY INC - JOSEPH DOSSANTOS, ACTING CFO, LEAVES CELULARITY ON FEB 27, 2026 - SEC FILING CELULARITY INC - APPOINTS JOHN SPRAGUE AS ACTING CFO ON FEB 27, 2026 - SEC FILING Source text: [ID:n0001493152-26-009017] Further company coverage: CELU.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celularity
See all newsU.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Celularity hits over 4-month high on deal to manufacture MuseCell's cell therapy platform
Celularity rises on deal to manufacture MuseCell's cell therapy platform
Brief: Celularity And MuseCell Innovations® Announce U.S. Manufacturing Collaboration For The Dezawa Musecell® Platform